4. Hieber KA. Pharmacy Benefit Design Considerations. PBM Plus, Inc.; 2008

5. Klippel JH. Excessive cost sharing as a barrier to health for people with arthritis. The American Journal of Pharmacy Benefits. 2012;4(1):38-39.

Continue Reading

6. Hargrave, E, Hoadley, J, Merrell, K, et al. Medicare Part D 2008 Data Spotlight: Specialty Tiers. Kaiser Family Foundation. http://www.kff.org/medicare/7711.cfm. Published December 10, 2007. Accessed January 4, 2013.

7. Reese S. Employers adopting specialty tiers. Managed Healthcare Executive. http://managedhealthcareexecutive.modernmedicine.com/mhe/article/articleDetail.jsp?id=754368. Published January 1, 2012. Accessed January 4, 2013.

8. Carroll J. Oral/Infusion Cancer Drug Parity Begins to Raise Health Plan Costs. Managed Care. http://www.managedcaremag.com/content/oralinfusion-cancer-drug-parity-begins-raise-health-plan-costs. Published January 2012. Accessed January 4, 2013.

9. Johson H. House Bill Summary: Part D Beneficiary Appeals Fairness Act. 

10. Rockefeller, J. S-1630 – Affordable Access to Prescriptions Medications Act of 2009.

11. Streeter S, Schwartzber L, Husain N, et al. Patient and plan characteristics affecting abandonment of oral oncolytic prescriptions. J Oncol Pract. 2011;7(3S):46s-51s.